HER 2 Positive Advanced Breast Cancer
3 clinical trials · Condition
◉ Watch HER 2 Positive Advanced Breast Cancer
| Record | Firm | Date |
|---|---|---|
| Phase Ib/II Study of Zanidatamab Plus Tucatinib and Chemotherapy in HER2-Positive Advanced Breast Cancer (NCT07494448) | MedSIR | 2026-07-01 |
| A Real-World Study of Pyrrolitinib Maleate Tablets for HER-2-Positive Early or Locally Advanced Breast Cancer After Adjuvant Trastuzumab Therapy (NCT06470347) | Zunyi Medical College | 2022-11-01 |
| Clinical Study of Recombinant Anti-HER2 Humanized Monoclonal Antibody (GB221) for Injection (NCT04164615) | Genor Biopharma Co., Ltd. | 2016-11-24 |
Track HER 2 Positive Advanced Breast Cancer automatically
Every clearance here is in the API, with alerts when new ones post.